Literature DB >> 8613858

Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm.

R M Pluta1, B G Thompson, T M Dawson, S H Snyder, R J Boock, E H Oldfield.   

Abstract

To determine the distribution of nitric oxide synthase (NOS) in the primate cerebral artery nervi vasorum and to examine the potential role of NOS in cerebral vasospasm after subarachnoid hemorrhage (SAH) in primates, the distribution of NOS immunoreactivity (NOS-IR) in the major cerebral arteries was examined immunohistochemically in cynomolgus monkeys by the use of whole, mounted preparations of the circle of Willis. In four normal monkeys, NOS-IR was localized to the endothelial and adventitial layers of the large cerebral arteries. On the abluminal side, NOS-IR staining was densely concentrated in perivascular nerve fibers (nervi vasorum) of the anterior circulation. Staining was less prominent in the posterior circulation. In six monkeys with vasospasm on Day 7 after placement of preclotted arterial blood to form an SAH around the right middle cerebral artery (MCA) (42% +/- 8.3% decrease of MCA area, mean +/- standard deviation), NOS-IR was virtually absent in nerve fibers around the spastic right MCA but was normal on the contralateral side. In five monkeys in which vasospasm resolved by Day 14 after SAH (36% +/- 14% decrease of right MCA area on Day 7, and 5% +/- 14% decrease on Day 14), NOS-IR was also absent in the right MCA adventitial nerve fibers and remained normal in the left MCA. Adventitial NOS-IR was also normal in cerebral vessels of a sham-operated, nonspastic monkey. These findings provide further evidence that nitric oxide (NO) functions as a neuronal transmitter to mediate vasodilation in primates and indicate a role for adventitial NO in the pathogenesis of cerebral vasospasm after SAH in humans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613858     DOI: 10.3171/jns.1996.84.4.0648

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  26 in total

1.  Reversal of cerebral vasospasm via intravenous sodium nitrite after subarachnoid hemorrhage in primates.

Authors:  Ali Reza Fathi; Ryszard M Pluta; Kamran D Bakhtian; Meng Qi; Russell R Lonser
Journal:  J Neurosurg       Date:  2011-09-02       Impact factor: 5.115

2.  Dopamine D2-receptor-mediated increase in vascular and endothelial NOS activity ameliorates cerebral vasospasm after subarachnoid hemorrhage in vitro.

Authors:  Gail J Pyne-Geithman; Danielle N Caudell; Matthew Cooper; Joseph F Clark; Lori A Shutter
Journal:  Neurocrit Care       Date:  2008-09-20       Impact factor: 3.210

3.  Partial antagonistic effect of adenosine on inverse coupling between spreading neuronal activation and cerebral blood flow in rats.

Authors:  Jens P Dreier; Katrin Tille; Ulrich Dirnagl
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

4.  Genetic elimination of eNOS reduces secondary complications of experimental subarachnoid hemorrhage.

Authors:  Mohammed Sabri; Jinglu Ai; Elliot Lass; Josephine D'abbondanza; R Loch Macdonald
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-03       Impact factor: 6.200

5.  Haptoglobin administration into the subarachnoid space prevents hemoglobin-induced cerebral vasospasm.

Authors:  Michael Hugelshofer; Raphael M Buzzi; Christian A Schaer; Henning Richter; Kevin Akeret; Vania Anagnostakou; Leila Mahmoudi; Raphael Vaccani; Florence Vallelian; Jeremy W Deuel; Peter W Kronen; Zsolt Kulcsar; Luca Regli; Jin Hyen Baek; Ivan S Pires; Andre F Palmer; Matthias Dennler; Rok Humar; Paul W Buehler; Patrick R Kircher; Emanuela Keller; Dominik J Schaer
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

6.  Effects of in vivo adventitial expression of recombinant endothelial nitric oxide synthase gene in cerebral arteries.

Authors:  A F Chen; S W Jiang; T B Crotty; M Tsutsui; L A Smith; T O'Brien; Z S Katusic
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

7.  "Optimal cerebral perfusion pressure" in poor grade patients after subarachnoid hemorrhage.

Authors:  Philippe Bijlenga; Marek Czosnyka; Karol P Budohoski; Martin Soehle; John D Pickard; Peter J Kirkpatrick; Peter Smielewski
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

Review 8.  Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH.

Authors:  R M Pluta
Journal:  Acta Neurochir Suppl       Date:  2008

9.  Endothelial nitric oxide synthase gene single-nucleotide polymorphism predicts cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Robert M Starke; Grace H Kim; Ricardo J Komotar; Zachary L Hickman; Eric M Black; Maritza B Rosales; Christopher P Kellner; David K Hahn; Marc L Otten; John Edwards; Tao Wang; James J Russo; Stephan A Mayer; Edward S Connolly
Journal:  J Cereb Blood Flow Metab       Date:  2008-03-05       Impact factor: 6.200

10.  Long-acting statin for aneurysmal subarachnoid hemorrhage: A randomized, double-blind, placebo-controlled trial.

Authors:  Masato Naraoka; Naoya Matsuda; Norihito Shimamura; Kenichiro Asano; Kenichi Akasaka; Atsuhito Takemura; Seiko Hasegawa; Hiroki Ohkuma
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-01       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.